China Largest Manuf...

China Largest Manufacturer factory sales Daidzein CAS 486-66-8
China Largest Manufacturer factory sales Daidzein CAS 486-66-8
China Largest Manufacturer factory sales Daidzein CAS 486-66-8
China Largest Manufacturer factory sales Daidzein CAS 486-66-8
China Largest Manufacturer factory sales Daidzein CAS 486-66-8

China Largest Manufacturer factory sales Daidzein CAS 486-66-8

Min.Order / FOB Price:Get Latest Price

500 Kilogram

FOB Price:USD 1.0000 -2.0000

  • Min.Order :500 Kilogram
  • Purity: 99%
  • Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Daidzein Daidzein 486-66-8

Quick Details

  • Appearance:white powder
  • Application:Pharm chemicals industry
  • PackAge:25KG/Drum
  • ProductionCapacity:20|Metric Ton|Month
  • Storage:2-8°C
  • Transportation:By air /Sea/ coruier

Superiority:

                                PRODUCT DETAILS                           

Daidzein Basic information
Product Name: Daidzein
Synonyms: 4’,7-dihydroxy-isoflavon;DAIDZEIN;Daidsein;4,7-Dihydroxyisoflavone(Daidzein);DAIDZEIN, (AMERICAN HERBAL PHARMACOPOEIA);DAIDZEIN, 98% SYNTHETIC;DAIDZEIN, STANDARD FROM SOYBEAN 99+%(HPLC);DAIDZEIN:4',7-DIHYDROXY ISOFLAVONE
CAS: 486-66-8
MF: C15H10O4
MW: 254.24
EINECS: 207-635-4
Product Categories: pharmacetical;Biochemistry;Iso-Flavones;Flavonoids;The group of Daidzin;Inhibitors;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;inhibitor;natural product;API;Tyrosine Kinase Inhibitors;Intracellular receptor;Indazoles
Mol File: 486-66-8.mol
Daidzein Structure
 
Daidzein Chemical Properties
Melting point  315-323°C (dec.)
Boiling point  317.45°C (rough estimate)
density  1.1629 (rough estimate)
refractive index  1.4300 (estimate)
storage temp.  2-8°C
solubility  DMSO: 10 mg/mL
pka 7.01±0.20(Predicted)
form  Powder
color  White to off-white
Water Solubility  insoluble
Merck  14,2801
BRN  231523
CAS DataBase Reference 486-66-8(CAS DataBase Reference)
EPA Substance Registry System 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)- (486-66-8)
 
Safety Information
Hazard Codes  Xi
Risk Statements  36/38
Safety Statements  24-26-37/39
WGK Germany  3
RTECS  DJ3100040
HazardClass  IRRITANT
HS Code  29329990
MSDS Information
Provider Language
4',7-Dihydroxyisoflavone English
ACROS English
SigmaAldrich English
ALFA English
 
Daidzein Usage And Synthesis
Description Daidzein mainly comes from leguminous plants, the seeds of soybean (dadou), red clover grass, or all Pueraria roots. Its medicinal value was first recorded in Shen Nong Ben Cao Jing 2838 BC. Daidzein, one of the main soy isoflavones, is also the main component of radix puerariae (Gegen) which is the dry root of kudzu leguminous plants. Radix puerariae can reduce fever, produce saliva, and relieve diarrhea. Its chemical composition is complicated, including puerarin, xyloside, soy flavonoids, soybean flavonoid glycosides, beta-sitosterol, daidzin, daidzein. The main effective components are puerarin and daidzein
Description Daidzein is an isoflavone phytoestrogenic compound that has been found in soybeans and other legumes. It binds to estrogen receptor β (ERβ; Ki = 2.8 μM) but not ERα at concentrations up to 1 mM. It is estrogenic in vitro, increasing gene transcription mediated by the estrogen response element (ERE) in a reporter assay in an ERβ-dependent manner (EC50 = 2.8 μM for MCF-7 cells expressing ERβ). Daidzein is an inhibitor of carbonic anhydrase (CA) that is selective for carbonic CAVII and CAXII (Kis = 4.2 and 56 nM, respectively) over CAI, II, and IV (Kis = >10,000, >10,000, and 718.7 nM, respectively). It reduces tumor growth in a PC3 prostate cancer mouse orthotopic model when administered at a dose of 50 mg/kg per day and potentiates the effects of radiation therapy.
Chemical Properties Off-White Crystalline Solid
Physical properties Appearance: pale-yellow prismatic crystal. Melting point: 315–323 °C. Solubility: soluble in ethanol and ether
History Daidzein is a kind of isoflavone compound, which was first synthetized by researchers in China. It has been widely used in drugs, food supplements, and cosmetics. Because of two phenolic hydroxyl structures, Daidzein has poor water solubility, poor liposolubility, and strong first-pass effect, leading to the low bioavailability of oral absorption, which limits its widely clinical usage.
Ipriflavone is a kind of isoflavone modified from Daidzein, which has been used for the treatment of osteoporosis in Japan and some European countries. The effects of a series of amino alkoxy derivatives of ipriflavones on inhibiting the bone absorption were evaluated. The researchers found that 7-amino alkoxy derivative works best. When Daidzein was alkylated or acylated at 7-hydroxyl selectively, the stability was increased, and thus the proliferation of MCF-7 cell was inhibited.
Uses Inactive analog of Genistein (Cat. #G350000). Blocks the G1 phase of the cell cycle in Swiss 3T3 cells by inhibiting casein kinase II activity1. Daidzein has also been shown to inhibit the action of GABA on recombinant GABAA receptors2. uv max:250 nm (log e 4.44)
Uses Daidzein belongs to the group of isoflavones. Daidzein and other isoflavone compounds, such as genistein, are present in a number of plants and herbs. Soy isoflavones are a group of compounds found in and isolated from the soybean. Besides functioning as
Uses phytoestrogen
Definition ChEBI: A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by an additional hydroxy group at position 4'.
Indications Daidzein is mainly used for the treatment of hypertension, coronary heart disease, cerebral thrombosis, and vertigo and aids in the treatment of sudden deafness. It can also treat women with menopause syndrome.
General Description

Daidzein is an endocrine-active estrogenic isoflavone. This phytoestrogen is capable to bind to estrogen to exert estrogenic effects in vivo. It can naturally be found in soybean seed and flour.

Biological Activity Analog of the phytoestrogen genistein (5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one ). Blocks G 1 phase cell cycle progression and is an agonist at estrogen receptors.
Biochem/physiol Actions Soy isoflavone daidzein protects against oxidative damage in liver cells induced by 7,12-dimethylbenz[a]anthracene (DMBA). Catalase and superoxide dismutase activity, down-regulated by DMBA, was restored by daidzein.
Pharmacology Daidzein has many kinds of pharmacological effects, such as anticancer, cardiovascular protection, estrogen- and antiestrogen-like effects, antiosteoporosis, antioxidation, improving immunity, and affecting the endocrine system. More attention has been paid by domestic and international pharmaceutical and food industries. Daidzein has obviously antibacterial effect on Staphylococcus aureus and Escherichia coli. It can also increase the weight of immune organs in mice and has anti-arrhythmic effect. The chemical structure of daidzein is very similar to the endogenous estrogen, so the estrogen-like effect is used to treat menopausal syndrome and increase the levels of osteocalcin (BGP) and also the bone mineral deposits. The clinical efficacy is similar to estrogen replacement therapy (ERT). Daidzein doesn’t induce the high expression of estrogen. It has effects on the osteoblast to reduce the bone absorption of osteoclast, thus maintains the dynamic balance of osteoblast and osteoclast, finally reduces the risk of fracture. So it is safe for usage. Daidzein can also increase the bone mineral density (BMD) and bone mineral content (BMC) of the lumbar spine, the number of trabecular bone, and bone volume fraction, improve the bone microstructure, and thus prevent the reduction of femur biomechanics in glucocorticoid-induced osteoporosis in the rat.
Daidzein has an anti-hypoxia effect. The study showed that Daidzein could significantly prolong the survival time of mice in hypoxia tolerance test under normal pressure and after subcutaneous injection of isoproterenol, suggesting that Daidzein has the significant anti-hypoxia effects. Daidzein plays a protective role in myocardial hypertrophy induced by isoproterenol in rat probably by the antioxidative effects. Similarly, Daidzein may protect the ischemia-reperfusion injury in rats by increasing the antioxidative capacity. Daidzein can significantly inhibit the proliferation of two human breast cancer cells (MCF-7 and MDA-MB-231) in vitro with the significant dose-dependent and time-dependent effects. Daidzein can markedly decrease the colony-forming ability, suggesting that Daidzein may have the effect of preventing and treating breast cancer.
It was found that Daidzein has the obviously preventive effect on chloroforminduced ventricular fibrillation in mice, therapeutic effect on aconitine-induced arrhythmia in rats, as well as protective effect on the adrenaline-induced arrhythmia in rabbit. Daidzein can significantly reduce the action potential amplitude of sciatic nerve in toad in vitro. All of the above effects were obviously dose-dependent, suggesting Daidzein has the significant anti-arrhythmic effects
Clinical Use Daidzein can expand the coronary artery, femoral artery, and cerebral artery, increase cerebral blood flow and limb blood circulation, reduce blood viscosity and vascular resistance, decrease myocardial oxygen consumption, improve heartfunction, increase the microcirculation and blood flow to the tip, lower the blood pressure, and adjust the heart rhythm. Daidzein can be used for the treatment of hypertension, coronary heart disease, angina pectoris, myocardial infarction, cerebral thrombosis, dizziness, and sudden deafness. It can also be used for women’s menopause syndrome.
 
Daidzein Preparation Products And Raw materials
Raw materials Ethanol-->Hydrochloric acid-->Diethyl ether
Preparation Products 6,7,4'-Trihydroxyisoflavone
 


                                                                       Group profiles


Leader Biochemical Group is a large leader incorporated industry manufacturers and suppliers of advanced refined raw materials From the year of 1996 when our factory was put into production to year of 2020, our group has successively invested in more than 52 factories with shares and subordinates.We focus on manufacture Pharm & chemicals, functional active ingredients, nutritional Ingredients, health care products, cosmetics, pharmaceutical and refined feed, oil, natural plant ingredients industries to provide top quality of GMP standards products.All the invested factories' product lines cover API and intermediates, vitamins, amino acids, plant extracts, daily chemical products, cosmetics raw materials, nutrition and health care products, food additives, feed additives, essential oil products, fine chemical products and agricultural chemical raw materials And flavors and fragrances. Especially in the field of vitamins, amino acids, pharmaceutical raw materials and cosmetic raw materials, we have more than 20 years of production and sales experience. All products meet the requirements of high international export standards and have been recognized by customers all over the world. Our manufacture basement & R&D center located in National Aerospace Economic & Technical Development Zone Xi`an Shaanxi China. Now not only relying on self-cultivation and development as well as maintains good cooperative relations with many famous research institutes and universities in China. Now, we have closely cooperation with Shanghai Institute of Organic Chemistry of Chinese Academy of Science, Beijing Institute of Material Medical of Chinese Academy of Medical Science, China Pharmaceutical University, Zhejiang University. Closely cooperation with them not only integrating Science and technology resources, but also increasing the R&D speed and improving our R&D power. Offering Powerful Tech supporting Platform for group development. Keep serve the manufacture and the market as the R&D central task, focus on the technical research.  Now there are 3 technology R & D platforms including biological extract, microorganism fermentation and chemical synthesis, and can independently research and develop kinds of difficult APIs and pharmaceutical intermediates. With the strong support of China State Institute of Pharmaceutical Industry (hereinafter short for CSIPI), earlier known as Shanghai Institute of Pharmaceutical Industry (SIPI), we have unique advantages in the R & D and industrialization of high-grade, precision and advanced products.  Now our Group technical force is abundant, existing staff more that 1000 people, senior professional and technical staff accounted for more than 50% of the total number of employees, including 15 PhD research and development personnel, 5 master′ S degree in technical and management personnel 9 people. We have advanced equipment like fermentation equipment and technology also extraction, isolation, purification, synthesis with rich production experience and strict quality control system, According to the GMP required, quickly transforming the R&D results to industrial production in time, it is our advantages and our products are exported to North and South America, Europe, Middle East, Africa, and other five continents and scale the forefront in the nation, won good international reputation.  We believe only good quality can bring good cooperation, quality is our key spirit during our production, we are warmly welcome clients and partner from all over the world contact us for everlasting cooperation, Leader will be your strong, sincere and reliable partner in China.

Our Factories production lines

                                                   Our Factories R&D ability

                        Our Factories warehouse 

                

Details:

                                                       Product information

Daidzein Basic information
Product Name: Daidzein
Synonyms: 4’,7-dihydroxy-isoflavon;DAIDZEIN;Daidsein;4,7-Dihydroxyisoflavone(Daidzein);DAIDZEIN, (AMERICAN HERBAL PHARMACOPOEIA);DAIDZEIN, 98% SYNTHETIC;DAIDZEIN, STANDARD FROM SOYBEAN 99+%(HPLC);DAIDZEIN:4',7-DIHYDROXY ISOFLAVONE
CAS: 486-66-8
MF: C15H10O4
MW: 254.24
EINECS: 207-635-4
Product Categories: pharmacetical;Biochemistry;Iso-Flavones;Flavonoids;The group of Daidzin;Inhibitors;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;inhibitor;natural product;API;Tyrosine Kinase Inhibitors;Intracellular receptor;Indazoles
Mol File: 486-66-8.mol
Daidzein Structure
 
Daidzein Chemical Properties
Melting point  315-323°C (dec.)
Boiling point  317.45°C (rough estimate)
density  1.1629 (rough estimate)
refractive index  1.4300 (estimate)
storage temp.  2-8°C
solubility  DMSO: 10 mg/mL
pka 7.01±0.20(Predicted)
form  Powder
color  White to off-white
Water Solubility  insoluble
Merck  14,2801
BRN  231523
CAS DataBase Reference 486-66-8(CAS DataBase Reference)
EPA Substance Registry System 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)- (486-66-8)
 
Safety Information
Hazard Codes  Xi
Risk Statements  36/38
Safety Statements  24-26-37/39
WGK Germany  3
RTECS  DJ3100040
HazardClass  IRRITANT
HS Code  29329990
MSDS Information
Provider Language
4',7-Dihydroxyisoflavone English
ACROS English
SigmaAldrich English
ALFA English
 
Daidzein Usage And Synthesis
Description Daidzein mainly comes from leguminous plants, the seeds of soybean (dadou), red clover grass, or all Pueraria roots. Its medicinal value was first recorded in Shen Nong Ben Cao Jing 2838 BC. Daidzein, one of the main soy isoflavones, is also the main component of radix puerariae (Gegen) which is the dry root of kudzu leguminous plants. Radix puerariae can reduce fever, produce saliva, and relieve diarrhea. Its chemical composition is complicated, including puerarin, xyloside, soy flavonoids, soybean flavonoid glycosides, beta-sitosterol, daidzin, daidzein. The main effective components are puerarin and daidzein
Description Daidzein is an isoflavone phytoestrogenic compound that has been found in soybeans and other legumes. It binds to estrogen receptor β (ERβ; Ki = 2.8 μM) but not ERα at concentrations up to 1 mM. It is estrogenic in vitro, increasing gene transcription mediated by the estrogen response element (ERE) in a reporter assay in an ERβ-dependent manner (EC50 = 2.8 μM for MCF-7 cells expressing ERβ). Daidzein is an inhibitor of carbonic anhydrase (CA) that is selective for carbonic CAVII and CAXII (Kis = 4.2 and 56 nM, respectively) over CAI, II, and IV (Kis = >10,000, >10,000, and 718.7 nM, respectively). It reduces tumor growth in a PC3 prostate cancer mouse orthotopic model when administered at a dose of 50 mg/kg per day and potentiates the effects of radiation therapy.
Chemical Properties Off-White Crystalline Solid
Physical properties Appearance: pale-yellow prismatic crystal. Melting point: 315–323 °C. Solubility: soluble in ethanol and ether
History Daidzein is a kind of isoflavone compound, which was first synthetized by researchers in China. It has been widely used in drugs, food supplements, and cosmetics. Because of two phenolic hydroxyl structures, Daidzein has poor water solubility, poor liposolubility, and strong first-pass effect, leading to the low bioavailability of oral absorption, which limits its widely clinical usage.
Ipriflavone is a kind of isoflavone modified from Daidzein, which has been used for the treatment of osteoporosis in Japan and some European countries. The effects of a series of amino alkoxy derivatives of ipriflavones on inhibiting the bone absorption were evaluated. The researchers found that 7-amino alkoxy derivative works best. When Daidzein was alkylated or acylated at 7-hydroxyl selectively, the stability was increased, and thus the proliferation of MCF-7 cell was inhibited.
Uses Inactive analog of Genistein (Cat. #G350000). Blocks the G1 phase of the cell cycle in Swiss 3T3 cells by inhibiting casein kinase II activity1. Daidzein has also been shown to inhibit the action of GABA on recombinant GABAA receptors2. uv max:250 nm (log e 4.44)
Uses Daidzein belongs to the group of isoflavones. Daidzein and other isoflavone compounds, such as genistein, are present in a number of plants and herbs. Soy isoflavones are a group of compounds found in and isolated from the soybean. Besides functioning as
Uses phytoestrogen
Definition ChEBI: A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone substituted by an additional hydroxy group at position 4'.
Indications Daidzein is mainly used for the treatment of hypertension, coronary heart disease, cerebral thrombosis, and vertigo and aids in the treatment of sudden deafness. It can also treat women with menopause syndrome.
General Description

Daidzein is an endocrine-active estrogenic isoflavone. This phytoestrogen is capable to bind to estrogen to exert estrogenic effects in vivo. It can naturally be found in soybean seed and flour.

Biological Activity Analog of the phytoestrogen genistein (5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one ). Blocks G 1 phase cell cycle progression and is an agonist at estrogen receptors.
Biochem/physiol Actions Soy isoflavone daidzein protects against oxidative damage in liver cells induced by 7,12-dimethylbenz[a]anthracene (DMBA). Catalase and superoxide dismutase activity, down-regulated by DMBA, was restored by daidzein.
Pharmacology Daidzein has many kinds of pharmacological effects, such as anticancer, cardiovascular protection, estrogen- and antiestrogen-like effects, antiosteoporosis, antioxidation, improving immunity, and affecting the endocrine system. More attention has been paid by domestic and international pharmaceutical and food industries. Daidzein has obviously antibacterial effect on Staphylococcus aureus and Escherichia coli. It can also increase the weight of immune organs in mice and has anti-arrhythmic effect. The chemical structure of daidzein is very similar to the endogenous estrogen, so the estrogen-like effect is used to treat menopausal syndrome and increase the levels of osteocalcin (BGP) and also the bone mineral deposits. The clinical efficacy is similar to estrogen replacement therapy (ERT). Daidzein doesn’t induce the high expression of estrogen. It has effects on the osteoblast to reduce the bone absorption of osteoclast, thus maintains the dynamic balance of osteoblast and osteoclast, finally reduces the risk of fracture. So it is safe for usage. Daidzein can also increase the bone mineral density (BMD) and bone mineral content (BMC) of the lumbar spine, the number of trabecular bone, and bone volume fraction, improve the bone microstructure, and thus prevent the reduction of femur biomechanics in glucocorticoid-induced osteoporosis in the rat.
Daidzein has an anti-hypoxia effect. The study showed that Daidzein could significantly prolong the survival time of mice in hypoxia tolerance test under normal pressure and after subcutaneous injection of isoproterenol, suggesting that Daidzein has the significant anti-hypoxia effects. Daidzein plays a protective role in myocardial hypertrophy induced by isoproterenol in rat probably by the antioxidative effects. Similarly, Daidzein may protect the ischemia-reperfusion injury in rats by increasing the antioxidative capacity. Daidzein can significantly inhibit the proliferation of two human breast cancer cells (MCF-7 and MDA-MB-231) in vitro with the significant dose-dependent and time-dependent effects. Daidzein can markedly decrease the colony-forming ability, suggesting that Daidzein may have the effect of preventing and treating breast cancer.
It was found that Daidzein has the obviously preventive effect on chloroforminduced ventricular fibrillation in mice, therapeutic effect on aconitine-induced arrhythmia in rats, as well as protective effect on the adrenaline-induced arrhythmia in rabbit. Daidzein can significantly reduce the action potential amplitude of sciatic nerve in toad in vitro. All of the above effects were obviously dose-dependent, suggesting Daidzein has the significant anti-arrhythmic effects
Clinical Use Daidzein can expand the coronary artery, femoral artery, and cerebral artery, increase cerebral blood flow and limb blood circulation, reduce blood viscosity and vascular resistance, decrease myocardial oxygen consumption, improve heartfunction, increase the microcirculation and blood flow to the tip, lower the blood pressure, and adjust the heart rhythm. Daidzein can be used for the treatment of hypertension, coronary heart disease, angina pectoris, myocardial infarction, cerebral thrombosis, dizziness, and sudden deafness. It can also be used for women’s menopause syndrome.
 
Daidzein Preparation Products And Raw materials
Raw materials Ethanol-->Hydrochloric acid-->Diethyl ether
Preparation Products 6,7,4'-Trihydroxyisoflavone
 

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View